Robert E. Gerszten, MD is Director of Clinical and Translational Research of the Massachusetts General Hospital (MGH) Heart Center, and a member of the MGH Executive Committee on Research. He is a Professor of Medicine at Harvard Medical School, and a Senior Associate Member of the Broad Institute. Dr. Gerszten graduated from the University of Virginia as an Echols Scholar and President’s Distinguished Scholar, then entered medical school at the Johns Hopkins University School of Medicine. He performed cardiovascular research and clinical fellowships at the Cardiovascular Research Institute at UCSF, and the Cardiovascular Research Center (CVRC), MGH. He joined the MGH faculty in 1999.
Dr. Gerszten’s laboratory focuses on the nexus of cardiac and metabolic diseases. His group makes observations in human models then turns to cell and animal systems to test for causal relationships. To expand the novelty and clinical impact of his studies, his group has incorporated emerging metabolomics and proteomic technologies towards the discovery of new biomarkers and pathways contributing to atherogenesis and its complications. His studies incorporate basic molecular and cell biology, human genetics, bioinformatics, mass spectrometry (and now Somascans…) all with a foundation in clinical medicine.
« Go Back